Fundz

Psilera Inc. secures a $2 million NIH grant for AUD research to advance neuroplastogens as a potential treatment for Alcohol Use Disorder.

PRIVATEOct 02, 2025

Amount Raised

A$2 Million

Round Type

Grant

TampaBiotechnologyHealth CareScience And Engineering

Description

Psilera Inc. announced receipt of a grant from the NIH to conduct research on Alcohol Use Disorder (AUD). This three-year, milestone-driven grant is worth up to $2 million. The funding will enable Psilera to advance their research quickly, addressing the significant unmet need in AUD treatment options

Quick answer

Psilera raised A$2 Million in a Grant round, dated October 2, 2025. Psilera is based in Tampa, Florida, United States.

How much did Psilera raise?
Psilera raised A$2 Million in a Grant round on October 2, 2025.
What does Psilera do?
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders.
Where is Psilera based and how big is it?
Psilera is based in Tampa, Florida, United States. Fundz records about 14 employees.
Who are the decision-makers at Psilera?
Fundz holds 1 contact at Psilera, including the Co-Founder and CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Biotechnology around the same time

Companies in the same sectors as Psilera that raised within 45 days of this round, from Fundz verified event records.

  • TandemAI raised $22M (Series A) on November 14, 2025.
  • Equillium raised $50M (Funding Round) on November 13, 2025.
  • PineTree Therapeutics raised $47M (Series B) on October 29, 2025.
  • Electra Therapeutics raised $183M (Series C) on October 22, 2025.
  • RedHill Biopharma Ltd raised $4M (Corporate Round) on October 20, 2025.
  • Theriva Biologics raised $13M on October 17, 2025.

Who to call at Psilera, and when

A new round usually means Psilera is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Psilera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Psilera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Psilera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Psilera

Location

3201 W. Hillsborough Ave., 151868

Tampa, Florida, United States

About

Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Psilera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChris, Co-Founder and CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Psilera's next move

See what Strategic adds

Psilera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.